EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Dementia risk estimation in persons at risk and the predictive turn in Alzheimer’s disease—The PreTAD project: Study protocol with an ethical, clinical, linguistic, and legal approach

Michelle Gerards iD, Annika Baumeister, Constanze Hübner, Federica Ribaldi iD, Yahveth Cantero-Fortiz iD, Julia Braun, Mercè Boada iD, Giovanni B Frisoni, Frank Jessen, Björn Schmitz-Luhn iD, Carolin Schwegler iD, Christiane Woopen und 1 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0319868 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Michelle Gerards und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research – BMBF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite progress in the field of Alzheimer’s disease (AD) dementia risk estimation, little is known about its impact at the individual and societal levels.

Objective

Introducing the explorative tri-national PreTAD project (The Predictive Turn in Alzheimer’s Disease: Ethical, Clinical, Linguistic and Legal Aspects), which aims to (1) learn about attitudes, needs, and perspectives on AD dementia risk estimation of the general population and cognitively unimpaired individuals with and without contact to memory clinics, (2) identify anticipated impacts of AD dementia risk estimation and (3) discuss the implications of the paradigm shift in medicine at individual and societal levels from an ethical, linguistic and legal perspective.

Methods

Different approaches are used: (1) an assessment of a population without experience with dementia, (2) an assessment in memory clinics, and (3) an online survey of the general population. Participants include cognitively healthy adults (n=2760), first-degree relatives of dementia patients (n=150), and participants with existing (n=150) and newly diagnosed (n=90) subjective cognitive decline (SCD) from Germany, Switzerland, and Spain.

Results

As part of the PreTAD project, new questionnaires are developed that (1) collect attitudes, needs, and perspectives on AD dementia risk estimation and (2) assess anticipated impacts of dementia risk estimation using hypothetical blood-based biomarker dementia risk scenarios.

Conclusion

The PreTAD study combines an interdisciplinary approach to develop a framework for predictive medicine in the preclinical stages of AD and supports improving communication of biomarker-based dementia risk estimation in clinical practice. The study was registered in the German Clinical Trials Register (DRKS00029035 on 03/08/2023).

Trial registration

German clinical trials register (Deutsches Register Klinischer Studien, DRKS): http://www.drks.de/DRKS00029035 , DRKS registration number: DRKS00029035, date of registration: 08.03.2023. Protocol version 3.0, date 01.06.2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDementiaHumansFemaleMaleRisk AssessmentGermanyAgedSurveys and QuestionnairesSwitzerlandSpainRisk FactorsCognitive DysfunctionMiddle Aged

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, Cologne, Germany.
  • Center for Life Ethics, TRA 4, University of Bonn, Bonn, Germany.
  • Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
  • Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
  • Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.
  • Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Michelle Gerards, Federica Ribaldi, Yahveth Cantero-Fortiz, Mercè Boada, Björn Schmitz-Luhn, Carolin Schwegler, Ayda Rostamzadeh

Förderung

  • Federal Ministry of Education and Research – BMBF

Zitieren

APA

Gerards, M., Baumeister, A., Hübner, C., Ribaldi, F., Cantero-Fortiz, Y., Braun, J., Boada, M., Frisoni, G. B., Jessen, F., Schmitz-Luhn, B., Schwegler, C., Woopen, C., & Rostamzadeh, A. (2025). Dementia risk estimation in persons at risk and the predictive turn in Alzheimer’s disease—The PreTAD project: Study protocol with an ethical, clinical, linguistic, and legal approach. PLOS One. https://doi.org/10.1371/journal.pone.0319868

Vancouver

Gerards M, Baumeister A, Hübner C, Ribaldi F, Cantero-Fortiz Y, Braun J, et al. Dementia risk estimation in persons at risk and the predictive turn in Alzheimer’s disease—The PreTAD project: Study protocol with an ethical, clinical, linguistic, and legal approach. PLOS One. 2025. doi:10.1371/journal.pone.0319868

BibTeX
@article{Gerards2025,
  author = {Gerards, Michelle and Baumeister, Annika and Hübner, Constanze and Ribaldi, Federica and Cantero-Fortiz, Yahveth and Braun, Julia and Boada, Mercè and Frisoni, Giovanni B and Jessen, Frank and Schmitz-Luhn, Björn and Schwegler, Carolin and Woopen, Christiane and Rostamzadeh, Ayda},
  title = {Dementia risk estimation in persons at risk and the predictive turn in Alzheimer’s disease—The PreTAD project: Study protocol with an ethical, clinical, linguistic, and legal approach},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0319868}
}
Kostenlos starten →